๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Suzhou
Clinical trial register · China

Clinical Trials in Suzhou, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 5484 Shanghai 3827 Guangzhou 3318 Hangzhou 1812 Wuhan 1343
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
The First Affiliated Hospital of Soochow University115 Second Affiliated Hospital of Soochow University16 Capital Medical University9 Novartis Pharmaceuticals8 Takeda8
Site location
Beijing5484 Shanghai3827 Guangzhou3318 Hangzhou1812 Wuhan1343
All 613 locations
Target enrolment
to

Trials with a site in Suzhou

421 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
Single-Needle Distal Return for Long-Term Arteriovenous Fistula Care
NCT07372027Hemodialysis Access, Arteriovenous Fistula, Arteriovenous Fistula Cannulation, Vascular Access
Suzhou Municipal Hospital of Anhui Province
Not applicable
100
Suzhou
2026-12-15
Recruiting
U69-CART-Cells For R/R T-ALL
NCT07350863Relapsed/Refractory T-lymphoblastic Leukemia/Lymphoma
The First Affiliated Hospital of Soochow University
Phase 1
12
Suzhou
2026-10-25
Not yet open
Mass Balance Study of [ยนโดC]Purinostat Mesylate for Injection in Healthy Participants
NCT07809217MB
Chengdu Zenitar Biomedical Technology Co., Ltd
Phase 1
6
Suzhou
2026-09-28
Not yet open
FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease Progression
NCT07540988Interstitial Lung Diseases
Boehringer Ingelheim
Phase 3
466
Beijing, Changsha, Chengdu, Guangzhou, Hangzhou, Nanjing, Shanghai, Suzhou
2026-09-14
Recruiting
Anisodine Hydrobromide for Patients With Acute Ischemic Stroke Undergoing Endovascular Therapy (HEAL-2)
NCT07800572Acute Ischemic Stroke
Capital Medical University
Phase 2
204
Anyang, Beijing, Huzhou, Jiuquan, Lishui, Shangqiu, Suzhou, Taizhou
2026-09-06
Recruiting
A Clinical Study of CT0596 CAR-T in Relapsed/Refractory Multiple Myeloma
NCT07760454Relapsed/Refractory Multiple Myeloma
UCARsgen Biotech Limited
Phase 1/2
68
Suzhou, Shanghai
2026-09-03
Not yet open
A Study of BL-M08D1 in Combination With Immunochemotherapy in Patients With Diffuse Large B-Cell Lymphoma
NCT07818499Diffuse Large B-Cell Lymphoma
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 1/2
204
Guangzhou, Suzhou
2026-09
Not yet open
Sonrotoclax, Glofitamab, Gemcitabine, and Oxaliplatin for Relapsed or Refractory Large B-Cell Lymphoma
NCT07774234Large B-Cell Lymphoma (LBCL), High-grade B-cell Lymphoma
The First Affiliated Hospital of Soochow University
Phase 2
39
Suzhou
2026-08-20
Not yet open
Tirzepatide in Thrombectomy-Treated Acute Ischemic Stroke: A Randomized Trial
NCT07734792Acute Ischemic Stroke (AIS)
yifang zhu
Phase 2/3
430
Suzhou
2026-08-10
Recruiting
Probiotics Improve Constipation
NCT07765004Constipation
Wecare Probiotics Co., Ltd.
Not applicable
76
Suzhou
2026-08-07
Not yet open
Phase โ…ข Clinical Trial to Evaluate the Efficacy and Safety of TJ0113 Capsules in Patients With Early-Onset Parkinson's Disease
NCT07741045Parkinson's Disease (PD), Parkinson Disease 6, Early-Onset
Hangzhou PhecdaMed Co., Ltd.
Phase 3
300
Beijing, Chongqing, Guangzhou, Zhengzhou, Wuhan, Changsha, Suzhou, Shanghai
2026-08-03
Not yet open
Safety and Feasibility of FMT for Immune Recovery After HSCT
NCT07755319Humoral Immunodeficiency, Hematopoietic Stem Cell Transplantation
The First Affiliated Hospital of Soochow University
Phase 1/2
86
Suzhou
2026-08-01
Not yet open
Cousin vs. Sibling Donors in Haplo-HSCT
NCT07662382Hematopoietic Malignancies, Haploidentical Hematopoietic Stem Cell Transplantation, Donor
The First Affiliated Hospital of Soochow University
Observational
1,000
Suzhou
2026-08-01
Not yet open
A Study of VABu Conditioning Regimen in Allo-HSCT for AML Patients
NCT07762508Leukemia, Myeloid, Acute(AML), Hematopoietic Stem Cell Transplantation (HSCT)
The First Affiliated Hospital of Soochow University
Not applicable
42
Suzhou
2026-08
Not yet open
A Study of Brenipatide (LY3537031) in Adult Participants With Major Depressive Disorder
NCT07775300Depressive Disorder, Major
Eli Lilly and Company
Phase 3
1,000
Beijing, Chaohu, Jinan, Linfen, Shanghai, Suzhou, Tianjin, Wenzhou
2026-08
Not yet open
A Longitudinal Study of Parental Sleep Intervention for Behavioral Insomnia in Early Childhood
NCT07420504Behavioural Insomnia of Childhood
Children's Hospital of Soochow University
Not applicable
30
Suzhou
2026-08
Not yet open
U96-CAR-T-Cells For R/R B-ALL
NCT07511426Relapsed or Refractory B Cell Leukemia and Lymphoma
The First Affiliated Hospital of Soochow University
Phase 1
30
Suzhou
2026-07-30
Recruiting
Adults With Constipation
NCT07529457Constipation
Wecare Probiotics Co., Ltd.
Not applicable
70
Suzhou
2026-07-24
Not yet open
A Study of Glofitamab Plus GemOx Compared With Standard of Care in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma
NCT07599423Diffuse Large B Cell Lymphoma (DLBCL)
The First Affiliated Hospital of Soochow University
Phase 2
96
Suzhou
2026-07-22
Not yet open
Younger vs. Older Donors in Allo-HSCT: TTE
NCT07666568A Target Trial Emulation Study, Donor Age, ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
The First Affiliated Hospital of Soochow University
Observational
5,000
Suzhou
2026-07-15
Recruiting
Evaluation of Bioequivalence and Food Effect of a New Strength Formulation of Ammoxetine Hydrochloride Enteric-coated Tablets in Healthy Participants.
NCT07756996Healthy Participants
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Phase 1
62
Suzhou
2026-07-15
Recruiting
Polypills Approach for Multiple Cardiovascular Risk Factors
NCT07679828Hypertension, Dyslipidemia, Diabetes
China Medical University, China
Not applicable
8,252
Zhengzhou, Chifeng, Tongliao, Kunshan, Suzhou, Taizhou, Jinzhou, Panjin
2026-07-11
Recruiting
Material Balance of [14C]Zorifertinib in Healthy Adult Male Participants in China
NCT07620951EGFR Mutant Advanced Non-small Cell Lung Cancer, Central Nervous System (CNS) Metastases
Alpha Biopharma (Jiangsu) Co., Ltd.
Phase 1
8
Suzhou
2026-07-06
Recruiting
Ruxolitinib Cream Combined With Corticosteroids for Progressive Non-Segmental Vitiligo: A Multicenter Real-World Study
NCT07673640Non-Segmental Vitiligo (NSV)
ShanShan Li
Observational
300
Shenzhen, Huai'an, Suzhou, Xuzhou, Dongying, Shanghai, Changzhou, Jiaozuo
2026-07-02
Not yet open
Finerenone for Regression of Albuminuria in Type 2 Diabetes With Chronic Kidney Disease
NCT07667517Albuminuria, Type 2 Diabetes Mellitus (T2DM), Chronic Kidney Diseases
First Affiliated Hospital of Zhejiang University
Phase 4
148
Chongqing, Fuzhou, Foshan, Guangzhou, Nantong, Suqian, Suzhou, Xi'an
2026-07-01
Not yet open
A Single-center, Prospective, Single-arm Clinical Study Exploring the Treatment of Newly Diagnosed Multiple Myeloma Patients With t(11;14) Suitable for Transplantation Using the SonKRd Regimen
NCT07709884Newly Diagnosed Multiple Myeloma, T(11;14), Sotoclax, Carfilzomib
The First Affiliated Hospital of Soochow University
Phase 4
20
Suzhou
2026-07-01
Recruiting
An Investigational Study of BG-75202 Alone and in Combination With Other Agents in Patients With Myeloid Malignancies
NCT07619287Myeloid Malignancy
BeOne Medicines
Phase 1
118
Lanzhou, Guangzhou, Shijiazhuang, Zhengzhou, Wuhan, Suzhou, Nanchang, Tianjin
2026-06-23
Recruiting
Qishen Yiqi Dripping Pills in Treatment of Chronic Heart FailUre
NCT07687186Heart Failure
Tasly Pharmaceutical Group Co., Ltd
Phase 3
636
Bozhou, Hefei, Suzhou, Beijing, Fuzhou, Lanzhou, Qingyang, Dongguan
2026-06-22
Not yet open
A Single-arm, Multicenter Clinical Study of Fruquintinib Combined With Serplulimab and Chemotherapy as First-line Treatment for Patients With RAS/BRAF-mutated Advanced Colorectal Cance
NCT07622550Metastatic Colorectal Cancer (CRC)
Jiangsu Cancer Institute & Hospital
Phase 2
80
Changzhou, Huai'an, Lianyungang, Nanjing, Nantong, Suzhou, Wuxi, Xuzhou
2026-06-15
Recruiting
A Study of Automated Axicabtagene Ciloleucel for R/R Large B-cell Lymphoma.
NCT07606937Relapsed/Refractory Large B-cell Lymphoma
Shenzhen Fosun Kairos Biotechnology Co., Ltd.
Phase EARLY_PHASE1
12
Beijing, Guangzhou, Suzhou, Shanghai, Chengdu, Tianjin
2026-06-12
Recruiting
ASCEND-1: Lifestyle Intervention Plus Mazdutide for Weight Management
NCT07517042Obesity, Weight Control
Shanghai Zhongshan Hospital
Not applicable
420
Chongqing, Fuzhou, Xiamen, Wuhan, Nanjing, Suzhou, Shanghai, Luzhou
2026-06-10
Recruiting
Probiotic Improve Constipation
NCT07462481Constipation
Wecare Probiotics Co., Ltd.
Not applicable
105
Suzhou
2026-06-10
Not yet open
Probiotics for Constipation Relief in Adults
NCT07507955Functional Constipation
Wecare Probiotics Co., Ltd.
Not applicable
105
Suzhou
2026-06-10
Recruiting
A Study to Evaluate the Efficacy of NIO752 in Participants With Progressive Supranuclear Palsy
NCT07498426Progressive Supranuclear Palsy Richardson Syndrome (PSP-RS)
Novartis Pharmaceuticals
Phase 3
300
Shanghai, Suzhou
2026-06-03
Recruiting
A Phase I Study of SHR-3836 in Patients With Multiple Myeloma
NCT07490613Multiple Myeloma
Shanghai Hengrui Pharmaceutical Co., Ltd.
Phase 1
99
Suzhou
2026-06-02
Recruiting
An Open-label, Single-arm, Multicenter Phase II Clinical Study of Azacitidine, Chidamide Combined With PD-1 Monoclonal Antibody in the Treatment of Refractory/Relapsed Peripheral T-cell Lymphoma.
NCT07598578Peripheral T-Cell Lymphoma Refractory
Second Affiliated Hospital of Soochow University
Phase EARLY_PHASE1
30
Suzhou
2026-06-01
Recruiting
Venetoclax TDM in Newly Diagnosed AML: Exposure-Response and Prognosis
NCT07670130Acute Myeloid Leukemia (AML)
The First Affiliated Hospital of Soochow University
Observational
50
Suzhou
2026-06-01
Not yet open
AI-Integrated Emotional Granularity Training for Resilience and Quality of Life in Colorectal Cancer Survivors
NCT07611071Colorectal Cancer (CRC)
The Hong Kong Polytechnic University
Not applicable
54
Kunshan, Suzhou, Suzhu
2026-06-01
Recruiting
CMV-CMI in csCMVi After HSCT
NCT07688759Cytomegalovirus Infections, Hematopoietic Stem Cell Transplantation (HSCT), Immune Reconstitution
The First Affiliated Hospital of Soochow University
Observational
40
Suzhou
2026-06-01
By invitation
Effect of Liposomal Bupivacaine and Bupivacaine Hydrochloride for Superior Trunk Block of the Interscalene Brachial Plexus on Postoperative Diaphragmatic Function and Analgesia
NCT07587203Proximal Humerus Surgery, Rotator Cuff Surgery, Shoulder Arthroplasty, Shoulder Arthroscopy
Nanjing First Hospital, Nanjing Medical University
Not applicable
184
Nanjing, Suzhou
2026-06-01
Not yet open
VA Induction and Bridging Transplantation for Hypoplastic/Secondary AML
NCT07635485Hypoplastic Acute Myeloid Leukemia, Secondary AML (Adult)
The First Affiliated Hospital of Soochow University
Not applicable
50
Suzhou
2026-06-01
Recruiting
VA Consolidation in Intermediate-Risk AML
NCT07672262Acute Myeloid Leukemia, Intermediate Risk Acute Myeloid Leukemia, Consolidation Therapy
The First Affiliated Hospital of Soochow University
Phase 2
226
Suzhou
2026-06-01
Not yet open
SHR2554/AZA + Overlapped Modified BUCY for High-risk/Relapsed Leukemia/MDS
NCT07575412Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, MDS, Transplantation, Stem Cell
The First Affiliated Hospital of Soochow University
Phase 2
180
Suzhou
2026-06
Not yet open
SHR2554/AZA + Overlapped TBF for High-risk/Relapsed Leukemia/MDS
NCT07562568Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, MDS, Transplantation, Stem Cell
The First Affiliated Hospital of Soochow University
Phase 2
160
Suzhou
2026-06
Recruiting
A Dose REgimen-Finding Study of AGA2115 in Chinese Patients With Osteogenesis ImpeRfecta (EIR)
NCT07557446Osteogenesis Imperfecta (OI)
Angitia Biopharmaceuticals Guangzhou Limited
Phase 2
48
Beijing, Shenzhen, Suzhou, Shanghai
2026-06
Recruiting
A Study to Evaluate the Efficacy and Safety of Rozanolixizumab in Adult Participants With Ocular Myasthenia Gravis
NCT07463521Ocular Myasthenia Gravis
UCB Biopharma SRL
Phase 3
120
Beijing, Chengdu, Nanchang, Suzhou
2026-05-27
Active, closed
LLM-CoManage: Large Language Model-Enabled Co-Management of Hypertension, Diabetes, and Dyslipidemia
NCT07350486Hypertension, Diabetes, Dyslipidemia
First Hospital of China Medical University
Not applicable
6,800
Cangzhou, Suzhou, Panjin, Shenyang, Jinzhou, Tianjin
2026-05-14
Recruiting
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
NCT07567001Obesity, Heart Failure
Novo Nordisk A/S
Phase 3
5,610
Guangzhou, Shijiazhuang, Harbin, Changsha, Baotou, Changzhou, Nanjing, Suzhou
2026-05-11
Recruiting
TP04HN106 in the Treatment of Patients With Amyotrophic Lateral Sclerosis
NCT06726577Amyotrophic Lateral Sclerosis
Talengen Institute of Life Sciences, Shenzhen, P.R. China.
Phase 1/2
60
Suzhou
2026-05-10
Recruiting
VABu Conditioning in Elderly AML HSCT
NCT07583888Allogeneic Hematopoietic Stem Cell Transplantation Recipient, Acute Myeloid Leukemia (AML)
The First Affiliated Hospital of Soochow University
Phase 2/3
20
Suzhou
2026-05-07
Recruiting
AMAZE 3: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Not Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea
NCT07571005Obesity, Overweight, Obstructive Sleep Apnoea
Novo Nordisk A/S
Phase 3
300
Beijing, Nanjing, Suzhou, Zhenjiang, Huzhou
2026-05-05
Recruiting
A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease
NCT07483099Crohn Disease
Eli Lilly and Company
Phase 2
60
Changsha, Changzhou, Guangzhou, Hangzhou, Huizhou, Suzhou, Wenzhou, Xiamen
2026-05-04
Recruiting
A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
NCT07483073Colitis, Ulcerative, Crohn Disease
Eli Lilly and Company
Phase 2
60
Changsha, Changzhou, Guangzhou, Hangzhou, Huizhou, Suzhou, Wenzhou, Xiamen
2026-05-04
Not yet open
A Phase 2 Study of Bcl-2 Inhibitor Combined With Azacitidine for Newly Diagnosed Mixed Phenotype Acute Leukemia
NCT07573670Newly Diagnosed Mixed Phenotype Acute Leukemia
The First Affiliated Hospital of Soochow University
Phase 2
52
Suzhou
2026-05-01
Recruiting
AI Model for Early Gastric Cancer Diagnosis Using Endoscopic Imaging
NCT07551466Early Gastric Cancer
The First Affiliated Hospital of Soochow University
Observational
100
Suzhou
2026-05-01
Recruiting
MRD-guided Maintenance Post-HCT: Gilteritini vs Sorafenib
NCT07463651Acute Myeloid Leukemia (AML), FLT3-ITD Mutation, Allogeneic Hematopoietic Cell Transplantation (HCT), Maintenance Therapy
The First Affiliated Hospital of Soochow University
Phase 3
594
Suzhou, Shanghai
2026-05-01
Not yet open
Pomalidomide Plus Anti-CD20 Antibody and Prednisone in Frontline Indolent B-Cell Lymphoma
NCT07609446Indolent Lymphoma, Follicular Lymphoma, Marginal Zone Lymphoma, Indolent Mantle Cell Lymphoma
The First Affiliated Hospital of Soochow University
Observational
30
Suzhou
2026-05-01
Recruiting
ZYG24002 Lotion to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy in Adult Patients With Mild to Moderate Seborrheic Dermatitis
NCT07404033Seborrheic Dermatitis
Sinomune Pharmaceutical Co., Ltd
Phase 1
48
Suzhou
2026-04-24
Recruiting
Efficacy, Safety, and PopPK Profile of ABP-745 in Patients With Atherosclerosis
NCT07303777Atherosclerosis Cardiovascular Disease, ASCVD, ASCVD Management
Atom Therapeutics Co., Ltd
Phase 2
200
Beijing, Dalian, Guangzhou, Hangzhou, Jinan, Nanjing, Shanghai, Suzhou
2026-04-23
Recruiting
Efficacy and Safety of Interleukin-6 Receptor Inhibitor Combined With Endovascular Treatment in Patients With Acute Posterior Circulation Large Vessel Occlusion Stroke
NCT07509645Ischemic Stroke
Capital Medical University
Phase 3
348
Suzhou, Anyang, Nanyang, Xinxiang, Zhoukou, Linyi, Zibo, Xianyang
2026-04-22
Recruiting
To Evaluate the Safety of SG2918 in Patients With Relapsed/Refractory Multiple Myeloma
NCT07454187Relapsed/Refractory Multiple Myeloma
Hangzhou Sumgen Biotech Co., Ltd.
Phase 1/2
40
Zhengzhou, Suzhou, Xiโ€™an, Hangzhou
2026-04-16
Recruiting
A Single-arm, Prospective Study of a Clad-LABU Conditioning Regimen in HSCT for R/R MDS/AML in Elderly Patients
NCT07500753Relapsed or Refractory Acute Myeloid Leukemia (AML), MDS (Myelodysplastic Syndrome)
The First Affiliated Hospital of Soochow University
Not applicable
30
Suzhou
2026-04-01
Recruiting
Effect of VR-MBCT in Chronic Nonspecific Low Back Pain
NCT07589790Chronic Non-specific Low Back Pain
The First Affiliated Hospital of Soochow University
Not applicable
214
Suzhou
2026-04-01
Recruiting
A Phase I Clinical Trial to Evaluate the Pharmacokinetic and Safety of Ammoxetine Hydrochloride Enteric-Coated Tablets in Participants With Mild Hepatic Impairment, Moderate Hepatic Impairment, and Normal Liver Function
NCT07694843Healthy Participants, Participants With Mild Hepatic Impairment, Participants With Moderate Hepatic Impairment
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Phase 1
24
Suzhou
2026-03-30
Recruiting
Methylprednisolone for Moderate to Severe Traumatic Brain Injury
NCT07180277Traumatic Brain Injury
Zhangjiagang First People's Hospital
Phase 4
520
Suzhou
2026-03-29
Recruiting
Safety and Efficacy of SC101 Via Perirenal Fat Injection for Resistant Hypertension in Patients With Moderate to Severe Chronic Kidney Disease
NCT07483372Resistant Arterial Hypertension, Chronic Kidney Disease (Stage 3-4)
The First Affiliated Hospital with Nanjing Medical University
Phase 1
3
Suzhou
2026-03-27
Recruiting
Trastuzumab Rezetecan Neoadjuvant Therapy in THP-Insensitive HER2-Positive Early Breast Cancer
NCT07647263HER2-positive Breast Cancer
The First Affiliated Hospital of Soochow University
Phase 2
124
Suzhou
2026-03-24
Recruiting
A Study to Evaluate the Safety of BG-A3004 in Healthy Participants and Patients With Immune-Mediated Skin Diseases
NCT07412691Skin Diseases
BeOne Medicines
Phase 1
98
Beijing, Chongqing, Fuzhou, Shijiazhuang, Changsha, Suzhou, Shenyang, Shanghai
2026-03-19
Recruiting
Study to Assess Safety and Efficacy of HDP-101 in Chinese Patients With Relapsed or Refractory Multiple Myeloma
NCT07529782Multiple Myeloma and Other Plasma Cell Neoplasms
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
Phase 1
15
Beijing, Suzhou, Jinan, Tianjin, Hangzhou
2026-03-17
Recruiting
Romiplostim for Oral TPO-RA Resistant ITP
NCT07612319Immune (Idiopathic) Thrombocytopenic Purpura (ITP)
The First Affiliated Hospital of Soochow University
Not applicable
60
Suzhou
2026-03-15
Recruiting
BY002 IIT Study in R/R Acute Leukemia
NCT07270770Acute Leukemia, KMT2A Rearrangements or NPM1 Mutations Acute Leukemia
The First Affiliated Hospital of Soochow University
Phase 1
18
Suzhou
2026-03-15
Active, closed
Mass Balance Study of [14C] D-2570
NCT07411742Mass Balance Study
InventisBio Co., Ltd
Phase 1
8
Suzhou
2026-03-10
Recruiting
Phase II Trial of RC1416 Injection in Asthma
NCT07403487Moderate to Severe Asthma
Nanjing RegeneCore Biotech Co., Ltd.
Phase 2
195
Anqing, Suzhou, Beijing, Chongqing, Lanzhou, Shijiazhuang, Tangshan, Xingtai
2026-03-10
Recruiting
Phase II Study of RC1416 Injection in COPD
NCT07402551Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
Nanjing RegeneCore Biotech Co., Ltd.
Phase 2
180
Hefei, Suzhou, Chongqing, Xiamen, Guangzhou, Huizhou, Jiangmen, Qingyuan
2026-03-06
Recruiting
A Phase 1 Clinical Study Comparing GS101 and Dupixentยฎ After Subcutaneous Injection
NCT07411755Atopic Dermatitis (AD)
Jiangsu Genscend Biopharmaceutical Co., Ltd
Phase 1
294
Suzhou
2026-03-05
Recruiting
Gelaspan vs Crystalloid Therapy in Sepsis
NCT07172451Sepsis, Intra-Abdominal Infections
Shanghai Zhongshan Hospital
Phase 4
318
Guangzhou, Nanjing, Suzhou, Xuzhou, Shanghai, Chengdu, Tianjing, Hangzhou
2026-02-13
Recruiting
A Study of Brenipatide in Adult Participants With Schizophrenia
NCT07410507Schizophrenia
Eli Lilly and Company
Phase 2
450
Changsha, Chengdu, Hangzhou, Suzhou, Tianjin, Wuhu, Xi'an, Zhumadian
2026-02-10
Recruiting
Venetoclax Combined With Azacitidine for Consolidation Therapy in AML
NCT07425782Acute Myeloid Leukemia, Consolidation Therapy, Venentoclax, High Risk
The First Affiliated Hospital of Soochow University
Phase 2
216
Suzhou
2026-02-01
Not yet open
Simple Swallowing Training Program on Older Individuals in the Community
NCT07373028Dysphagia
Zeng Changhao
Not applicable
474
Suzhou, Zhenzhou
2026-02
Recruiting
Romiplostim Versus rhTPO for Platelet Engraftment After Transplant in MDS and AA
NCT07400341MDS (Myelodysplastic Syndrome), Aplastic Anemia (AA)
The First Affiliated Hospital of Soochow University
Phase 2
66
Suzhou
2026-01-31
Not yet open
the Five-year Antibody Persistence After Immunization With IPV, MMR and HepA-L Vaccines
NCT07338851Polio, Measles, Rubella, Mumps
China National Biotec Group Company Limited
Observational
600
Suzhou, Handan, Yancheng, Hanzhong, Yuncheng, Mianyang
2026-01-30
Recruiting
A Multicenter Observational Study of Lemborexant on Insomnia Patients With Psychiatric Disorders
NCT07417813Insomnia, Psychiatric Disorders
Shanghai Mental Health Center
Observational
121
Suzhou, Xuzhou, Shanghai, Hangzhou, Ningbo
2026-01-24
Recruiting
Zeprumetostat, Azacitidine Combined With Lipo-MIT in R/R PTCL
NCT07372352Peripheral T Cells Lymphoma (PTCL)
The First Affiliated Hospital of Soochow University
Phase 2
26
Suzhou
2026-01-15
Recruiting
A Study to Assess the Real-World Effectiveness of Mavacamten in Adult Patients With Obstructive Hypertrophic Cardiomyopathy in China
NCT07361289Hypertrophic Cardiomyopathy
Bristol-Myers Squibb
Observational
500
Beijing, Guangzhou, Jiazhuang, Harbin, Zhengzhou, Suzhou, Changchun, Dalian
2026-01-15
Not yet open
Osteoporotic Vertebral Compression Fracture Cohort Study
NCT07321795OVCF Database, Cohort Study
Wangjing Hospital, China Academy of Chinese Medical Sciences
Observational
200
Hunan, Suzhou, Weihai, Beijing
2026-01-10
Recruiting
Bioequivalence Study of GZR18 Injection Before and After CMC Change
NCT07355738Obesity&T2D
Gan & Lee Pharmaceuticals.
Phase 1
138
Suzhou
2026-01-09
Active, closed
Construction and Validation of an Intelligent Ultrasound Diagnostic System for the Spectrum of Neuroblastoma in Children
NCT07549425Neuroblastic Tumors
The Children's Hospital of Zhejiang University School of Medicine
Observational
300
Hefei, Suzhou, Kunming, Hangzhou, Wenling
2026-01-01
Active, closed
Efficacy and Safety of Sequential Autologous Hematopoietic Stem Cell Transplantation Combined With Tafasitamab, Lenalidomide, and Standard Immunochemotherapy for Relapsed/Refractory Diffuse Large B-cell Lymphoma
NCT07621406Relapsed/Refractory Diffuse Large B Cell Lymphoma
The First Affiliated Hospital of Soochow University
Phase 2
25
Suzhou
2026-01-01
Active, closed
Efficacy of Vitamin D in Post-Stroke Cognitive Impairment
NCT07767214Post-Stroke Cognitive Impairment (PSCI)
Suzhou Municipal Hospital of Anhui Province
Not applicable
300
Suzhou
2026-01-01
Recruiting
Genetic Subtype-matched Targeted Therapy for the Treatment of Newly Diagnosed DLBCL With TP53 Mutation
NCT07499271Diffuse Large B-Cell Lymphoma (DLBCL)
The First Affiliated Hospital of Soochow University
Phase 2
35
Suzhou
2026-01-01
Recruiting
Safety and Efficacy Study of BAFF-R CAR-T Cells in Adult Subjects With CD19-Negative Relapsed or Refractory B-Cell Lymphoma
NCT07369492B-cell Lymphoma
Jiangsu Topcel-KH Pharmaceutical Co., Ltd.
Phase 1
30
Suzhou
2026-01-01
Recruiting
Safety and Efficacy Study of Anti-PD1 Armored CD19 CAR-T Cells in Adult Subjects With Relapsed or Refractory Diffuse Large B-cell Lymphoma
NCT07368270Diffuse Large B Cell Lymphoma
Jiangsu Topcel-KH Pharmaceutical Co., Ltd.
Phase 1
30
Suzhou
2026-01
Not yet open
Cetuximab ฮฒ Combined With PRaG Regimen in the Treatment of EGFR-positive Advanced Refractory Solid Tumors
NCT07327411Advanced Refractory Solid Tumors
Second Affiliated Hospital of Soochow University
Phase 2
40
Suzhou
2025-12-27
Active, closed
Efficacy and Safety of Home-based Structured Physical Exercise in Patients With Acute Ischemic Stroke
NCT07271082Acute Ischemic Stroke
Capital Medical University
Not applicable
208
Fuyang, Suzhou, Beijing, Zhoukou, Shihezi
2025-12-18
Recruiting
Albumin for Patients With Acute Large Vessel Occlusive Stroke Undergoing Endovascular Therapy -2
NCT07263308Acute Ischemic Stroke
Capital Medical University
Phase 3
1,192
Anqing, Bozhou, Fuyang, Maโ€™anshan, Suzhou, Wuhu, Beijing, Fuzhou
2025-12-18
Not yet open
Circulating Immune Markers for Prognostic Evaluation in Postoperative Lung Cancer Patients
NCT07242482Lung Cancer (Diagnosis), Biomarkers / Blood
Zhao Jun
Observational
200
Suzhou
2025-12-17
Not yet open
DPP4 Inhibitor Intervention on Post-stroke Cognitive Impairment in Ischemic Stroke Patients With Type 2 Diabetes
NCT07241897Ischemic Stroke, Diabete Mellitus
Second Affiliated Hospital of Soochow University
Phase 3
312
Suzhou
2025-12-15
Recruiting
A Phase Ia Study of KMY Tablets in Healthy Subjects
NCT07314541Healthy Volunteers
Lei Yunshang Group
Phase 1
120
Suzhou
2025-12-15
Recruiting
Near-infrared Light Therapy Device for Mild-Moderate Alzheimer's Disease (NirsCure-03A)
NCT07262645Alzheimer s Disease
Danyang Huichuang Medical Equipment Co., Ltd.
Phase 3
320
Beijing, Shijiazhuang, Baotou, Suzhou, Xi'an, Shanghai, Taiyuan, Tianjin
2025-12-15
Recruiting
Clinical Study of UTAA07 Injection in the Treatment of Hematologic and Lymphatic Systemic Malignancies
NCT07338604Hematolymphoid Malignancies
PersonGen BioTherapeutics (Suzhou) Co., Ltd.
Phase EARLY_PHASE1
15
Suzhou
2025-12-12
Rows per page Showing 1–100 of 421
1 2 3 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 24 September 2026. https://priyalifescience.com/clinical-trials-china/city/suzhou

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 421 of those studies with a site in Suzhou.

How many clinical trials are recruiting in Suzhou?

269 of the 421 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 53 have not yet opened recruitment, 87 are active but closed to new participants, and 12 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Suzhou), 421 studies
PhaseStudiesRecruitingShare
Not applicable875820.7%
Phase 2835519.7%
Phase 3763918.1%
Observational563213.3%
Phase 1463910.9%
Phase 1/236258.6%
Phase 2/31353.1%
Phase 41272.9%
Phase EARLY_PHASE11292.9%

Most active sponsors

Lead sponsors with the most studies (Suzhou)
Lead sponsorStudiesRecruiting
The First Affiliated Hospital of Soochow University11581
Second Affiliated Hospital of Soochow University1610
Capital Medical University95
Novartis Pharmaceuticals83
Takeda85
Wecare Probiotics Co., Ltd.76
AbbVie61
Children's Hospital of Soochow University65
Amgen50
Ascentage Pharma Group Inc.55
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.